RhumbLine Advisers’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
Other funds holding CTSO
SC
AC
GIM
SIG
CM
JAMONY
RhumbLine Advisers's CTSO Position: Q3 2023 in Review
RhumbLine Advisers sold out of Cytosorbents Corp (CTSO) in Q3 2023, closing a stake of 1,897 shares — an estimated $6.81K sold.
RhumbLine Advisers first reported a position in CTSO in Q2 2018 and held it in 17 quarters. The position peaked at $438K in Q2 2020. 53 funds tracked by Wall St. Rank hold CTSO as of Q3 2023.
- RhumbLine Advisers reported no remaining Cytosorbents Corp position as of Q3 2023 after selling out during the quarter.
- RhumbLine Advisers sold 1,897 Cytosorbents Corp shares in Q3 2023, an estimated $6.81K.
- RhumbLine Advisers first reported a position in Cytosorbents Corp in Q2 2018 and held it in 17 quarters.
- RhumbLine Advisers's Cytosorbents Corp position peaked at $438K in Q2 2020.
- 53 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2023.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.